S100B in myoblasts regulates the transition from activation to quiescence and from quiescence to activation and reduces apoptosis

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1813, Issue 5, 2011, Pages 1092-1104

  Tubaro, Claudia ^a   Arcuri, Cataldo ^a   Giambanco, Ileana ^a   Donato, Rosario ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Differentiation; Myoblast; Quiescence; S100B

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 7; MYOGENIN; PROTEIN KINASE B; PROTEIN S100B;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; MOUSE; MYOBLAST; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CULTURE MEDIA; CYTOPROTECTION; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HYDROGEN PEROXIDE; INTRACELLULAR SPACE; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MODELS, BIOLOGICAL; MYOBLASTS; MYOGENIN; NERVE GROWTH FACTORS; NF-KAPPA B; PROTO-ONCOGENE PROTEINS C-AKT; RATS; S100 PROTEINS;

EID: 79955646090     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2010.11.015     Document Type: Article

References (58)

1. Donato R., Sorci G., Riuzzi F., Arcuri C., Bianchi R., Brozzi F., Tubaro C., Giambanco I. S100B's double life: intracellular regulator and extracellular signal. Biochim. Biophys. Acta (Molecular Cell Research) 2009, 1793:1008-1022.
2. Donato R. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int. J. Biochem. Cell Biol. 2001, 33:637-668.
3. Heizmann C.W., Fritz G., Schaefer B.W. S100 proteins: structure, functions and pathology. Front. Biosci. 2002, 7:d1356-d1368.
4. Lin J., Yang Q., Yan Z., Markowitz J., Wilder P.T., Carrier F., Weber D.J. Inhibiting S100B restores p53 levels in primary malignant melanoma cancer cells. J. Biol. Chem. 2004, 279:34071-34077.
5. Arcuri C., Bianchi R., Brozzi F., Donato R. S100B increases proliferation in PC12 neuronal cells and reduces their responsiveness to NGF via Akt activation. J. Biol. Chem. 2005, 280:4402-4414.
6. Saito T., Ikeda T., Nakamura K., Chung U.I., Kawaguchi H. S100A1 and S100B, transcriptional targets of SOX trio, inhibit terminal differentiation of chondrocytes. EMBO Rep. 2007, 8:504-509.
7. Brozzi F., Arcuri C., Giambanco I., Donato R. S100B protein regulates astrocyte shape and migration via interaction with Src kinase: implications for astrocyte development, activation and tumor growth. J. Biol. Chem. 2009, 284:8797-8811.
8. Chargé S.B., Rudnicki M.A. Cellular and molecular regulation of muscle regeneration. Physiol. Rev. 2004, 84:209-238.
9. Buckingham M. Myogenic progenitor cells and skeletal myogenesis in vertebrates. Curr. Opin. Curr. Opin. Genet. Dev. 2006, 16:525-532.
10. Zammit P.S., Partridge T.A., Yablonka-Reuveni Z. The skeletal muscle satellite cell: the stem cell that came in from the cold. J. Histochem. Cytochem. 2006, 54:1177-1191.
11. Guttridge D.C., Mayo M.W., Madrid L.V., Wang C.Y., Baldwin A.S. NF-κB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science 2000, 289:2363-2366.
12. Langen R.C., Schols A.M., Kelders M.C., Wouters E.F., Janssen-Heininger Y.M. Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor-B. FASEB J. 2001, 15:1169-1180.
13. Acharyya S., Ladner K.J., Nelsen L.L., Damrauer J., Reiser P.J., Swoap S., Guttridge D.C. Cancer cachexia is regulated by selective targeting of skeletal muscle gene products. J. Clin. Invest. 2004, 114:370-378.
14. Kumar A., Murphy R., Robinson P., Wei L., Boriek A.M. Cyclic mechanical strain inhibits skeletal myogenesis through activation of focal adhesion kinase, Rac-1 GTPase, and NF-κB transcription factor. FASEB J. 2004, 18(2004):1524-1535.
15. Langen R.C., Van Der Velden J.L., Schols A.M., Kelders M.C., Wouters E.F., Janssen-Heininger Y.M. Tumor necrosis factor-α inhibits myogenic differentiation through MyoD protein destabilization. FASEB J. 2004, 18:227-237.
16. Dogra C., Changotra H., Mohan S., Kumar A. Tumor necrosis factor-like weak inducer of apoptosis inhibits skeletal myogenesis through sustained activation of nuclear factor-κB and degradation of MyoD protein. J. Biol. Chem. 2006, 281:10327-10336.
17. Mourkioti F., Kratsios P., Luedde T., Song Y.H., Delafontaine P., Adami R., Parente V., Bottinelli R., Pasparakis M., Rosenthal N. Targeted ablation of IKK2 improves skeletal muscle strength, maintains mass, and promotes regeneration. J. Clin. Invest. 2006, 116:2945-2954.
18. Acharyya S., Villalta S.A., Bakkar N., Bupha-Intr T., Janssen P.M., Carathers M., Li Z.W., Beg A.A., Ghosh S., Sahenk Z., Weinstein M., Gardner K.L., Rafael-Fortney J.A., Karin M., Tidball J.G., Baldwin A.S., Guttridge D.C. Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy. J. Clin. Invest. 2007, 117:889-901.
19. Wang H., Hertlein E., Bakkar N., Sun H., Acharyya S., Wang J., Carathers M., Davuluri R., Guttridge D.C. NF-κB regulation of YY1 inhibits skeletal myogenesis through transcriptional silencing of myofibrillar genes. Mol. Cell. Biol. 2007, 27:4374-4387.
20. Bakkar N., Wang J., Ladner K.J., Wang H., Dahlman J.M., Carathers M., Acharyya S., Rudnicki M.A., Hollenbach A.D., Guttridge D.C. IKK/NF-κB regulates skeletal myogenesis via a signaling switch to inhibit differentiation and promote mitochondrial biogenesis. J. Cell Biol. 2008, 180:787-802.
21. Sorci G., Agneletti A.L., Riuzzi F., Marchetti C., Donato R. S100B inhibits myogenic differentiation and myotube formation in a RAGE-independent manner. Mol. Cell. Biol. 2003, 23:4870-4881.
22. Riuzzi F., Sorci G., Donato R. S100B stimulates myoblast proliferation and inhibits myoblast differentiation by independently stimulating ERK1/2 and inhibiting p38 MAPK. J. Cell. Physiol. 2006, 207:461-470.
23. Sorci G., Bianchi R., Giambanco I., Rambotti M.G., Donato R. Replicating myoblasts and fused myotubes express the calcium-modulated proteins S100A1 and S100B. Cell Calcium 1999, 25:93-106.
24. Tubaro C., Arcuri C., Giambanco I., Donato R. S100B protein in myoblasts modulates myogenic differentiation via NF-κB-dependent inhibition of MyoD expression. J. Cell. Physiol. 2010, 223:270-282.
25. Olguin H.C., Olwin B.B. Pax-7 up-regulation inhibits myogenesis and cell cycle progression in satellite cells: a potential mechanism for self-renewal. Dev. Biol. 2004, 275:375-388.
26. Kitzmann M., Carnac G., Vandromme M., Primig M., Lamb N.J., Fernandez A. The muscle regulatory factors MyoD and myf-5 undergo distinct cell cycle-specific expression in muscle cells. J. Cell Biol. 1998, 142:1447-1459.
27. Yoshida N., Yoshida S., Koishi K., Masuda K., Nabeshima Y. Cell heterogeneity upon myogenic differentiation: down-regulation of MyoD and Myf-5 generates "reserve cells". J. Cell Sci. 1998, 111:769-779.
28. Zammit P.S., Heslop L., Hudon V., Rosenblatt J.D., Tajbakhsh S., Buckingham M.E., Beauchamp J.R., Partridge T.A. Kinetics of myoblast proliferation show that resident satellite cells are competent to fully regenerate skeletal muscle fibers. Exp. Cell Res. 2002, 281:39-49.
29. Wu Z., Woodring P.J., Bhakta K.S., Tamura K., Wen F., Feramisco J.R., Karin M., Wang J.Y.J., Puri P.L. p38 and extracellular signal-regulated kinases regulate the myogenic program at multiple steps. Mol. Cell. Biol. 2000, 20:3951-3964.
30. Lluis F., Perdiguerom E., Nebredam A.R., Munoz-Canoves P. Regulation of skeletal muscle gene expression by p38 MAP kinases. Trends Cell Biol. 2006, 16:36-44.
31. Miranda A.F., Nette E.G., Khan S., Brockbank K., Schonberg M. Alteration of myoblast phenotype by dimethyl sulfoxide. Proc. Natl. Acad. Sci. USA 1978, 75:3826-3830.
32. Blau H.M., Epstein C.J. Manipulation of myogenesis in vitro: reversible inhibition by DMSO. Cell 1979, 17:95-108.
33. Simone C., Forcales S.V., Hill D.A., Imbalzano A.N., Latella L., Puri P.L. p38 pathway targets SWI-SNF chromatin-remodeling complex to muscle-specific loci. Nat. Genet. 2004, 36:738-743.
34. Bennett A.M., Tonks N.K. Regulation of distinct stages of skeletal muscle differentiation by mitogen-activated protein kinases. Science 1997, 278:1288-1291.
35. Winter B., Arnold H.H. Activated Ras kinase inhibits muscle cell differentiation through a MEF2-dependent mechanism. J. Cell Sci. 1997, 113:4211-4220.
36. Serra C., Palacios D., Mozzetta C., Forcales S.V., Morante I., Ripani M., Jones D.R., Du K., Jhala U.S., Simone C., Puri P.L. Functional interdependence at the chromatin level between the MKK6/p38 IGF1/PI3K/AKT pathways during muscle differentiation. Mol. Cell 2007, 28:200-213.
37. Arcuri C., Giambanco I., Bianchi R., Donato R. Annexin V, annexin VI, S100A1 and S100B in developing and adult avian skeletal muscles. Neuroscience 2002, 109:371-388.
38. -/- satellite cells in single-fiber culture are differentiation defective and MRF4 deficient. Dev. Biol. 2000, 224:122-137.
39. Perdiguero E., Ruiz-Bonilla V., Serrano A.L., Muñoz-Cánoves P. Genetic deficiency of p38alpha reveals its critical role in myoblast cell cycle exit: the p38alpha-JNK connection. Cell Cycle 2007, 6:1298-1303.
40. Mbele G.O., Deloulme J.C., Gentil B.J., Delphin C., Ferro M., Garin J., Takahashi M., Baudier J. The zinc- and calcium-binding S100B interacts and co-localizes with IQGAP1 during dynamic rearrangement of cell membranes. J. Biol. Chem. 2002, 277:49998-50007.
41. Briggs M.W., Sacks D.B. IQGAP proteins are integral components of cytoskeletal regulation. EMBO Rep. 2003, 4:571-574.
42. Coso O.A., Chiariello M., Yu J.C., Teramoto H., Crespo P., Xu N., Miki T., Gutkind J.S. The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway. Cell 1995, 81:1137-1146.
43. Minden A., Lin A., Claret F.X., Abo A., Karin M. Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell 1995, 81:1147-1157.
44. Wu X., Tu X., Joeng K.S., Hilton M.J., Williams D.A., Long F. Rac1 activation controls nuclear localization of beta-catenin during canonical Wnt signaling. Cell 2008, 133:340-353.
45. Bianchi R., Adami C., Giambanco I., Donato R. The S100B binding to RAGE in microglia stimulates COX-2 expression. J. Leukoc. Biol. 2007, 81:108-118.
46. Asakura A., Hirai H., Kablar B., Morita S., Ishibashi J., Piras B.A., Christ A.J., Verma M., Vineretsky K.A., Rudnicki M.A. Increased survival of muscle stem cells lacking the MyoD gene after transplantation into regenerating skeletal muscle. Proc. Natl Acad. Sci. USA 2007, 104:16552-16557.
47. Urish K.L., Vella J.B., Okada M., Deasy B.M., Tobita K., Keller B.B., Cao B., Piganelli J.D., Huard J. Antioxidant levels represent a major determinant in the regenerative capacity of muscle stem cells. Mol. Biol. Cell 2009, 20:509-520.
48. Kumar A., Boriek A.M. Mechanical stress activates the nuclear factor-kappaB pathway in skeletal muscle fibers: a possible role in Duchenne muscular dystrophy. FASEB J. 2003, 17:386-396.
49. Catani M.V., Savini I., Duranti G., Caporossi D., Ceci R., Sabatini S., Avigliano L. Nuclear factor κB and activating protein 1 are involved in differentiation-related resistance to oxidative stress in skeletal muscle cells. Free Radic. Biol. Med. 2004, 37:1024-1036.
50. Mrak R.E., Sheng J.G., Griffin W.S. Glial cytokines in Alzheimer's disease: review and pathogenic implications. Hum. Pathol. 1995, 26:816-823.
51. Matsui T., Mori T., Tateishi N., Kagamiishi Y., Satoh S., Katsube N., Morikawa E., Morimoto T., Ikuta F., Asano T. Astrocytic activation and delayed infarct expansion after permanent focal ischemia in rats. Part I: enhanced astrocytic synthesis of s-100β in the periinfarct area precedes delayed infarct expansion. J. Cereb. Blood Flow Metab. 2002, 22:711-722.
52. Sheng J.G., Mrak R.E., Bales K.R., Cordell B., Paul S.M., Jones R.A., Woodward S., Zhou X.Q., McGinness J.M., Griffin W.S. Overexpression of the neuritotrophic cytokine S100beta precedes the appearance of neuritic beta-amyloid plaques in APPV717F mice. J. Neurochem. 2000, 74:295-301.
53. Wainwright M.S., Craft J.M., Griffin W.S., Marks A., Pineda J., Padgett K.R., Van Eldik L.J. Increased susceptibility of S100B transgenic mice to perinatal hypoxia-ischemia. Ann. Neurol. 2004, 56:61-67.
54. Mori T., Koyama N., Arendash G.W., Horikoshi-Sakuraba Y., Tan J., Town T. Overexpression of human S100B exacerbates cerebral amyloidosis and gliosis in the Tg2576 mouse model of Alzheimer's disease. Glia 2010, 58:300-314.
55. S. Beccafico, F. Riuzzi, C. Puglielli, R. Mancinelli, S. Fulle, G. Sorci, R. Donato, Human muscle satellite cells show age-related differential expression of S100B protein and RAGE. Age, DOI: 10.1007/s11357-010-9197-x.
56. Van Eldik L.J., Wainwright M.S. The Janus face of glial-derived S100B: beneficial and detrimental functions in the brain. Restor. Neurol. Neurosci. 2003, 21:97-108.
57. Mrak R.E., Griffin W.S. Trisomy 21 and the brain. J. Neuropathol. Exp. Neurol. 2004, 63:679-685.
58. Allore R., O'Hanlon D., Price R., Neilson K., Willard H.F., Cox D.R., Marks A., Dunn R.J. Gene encoding the β subunit of S100 protein is on chromosome 21: implications for Down syndrome. Science 1998, 239:1311-1313.